The US Food and Drug Administration (FDA) approved the latest versions of COVID-19 vaccines developed by Pfizer and Moderna which target newer variants of the SARS-CoV-2 virus, it was announced Monday. However, this time around, the US federal government is not covering the costs of the shots. The full price is expected to range between US$ 110 and US$ 130 per dose, it was reported. Read full article
Comments
Disclaimer & comment rulesCommenting for this story is now closed.
If you have a Facebook account, become a fan and comment on our Facebook Page!